End-Stage Renal Disease (Chronic Kidney Disease Stage 5) Protocol

Kidney HealthModerate Evidence

supplements

Primary

Supporting

Grade A

149

Studies

Primary Stack

Core supplements with strongest evidence

L-CarnitineB

1-2g daily (or IV after dialysis as prescribed)

Dialysis depletes carnitine; supplementation improves energy metabolism, reduces fatigue, and may improve cardiac function

↓Blood Pressure↓Total cholesterol↓Triglycerides↓Low-density lipoprotein (LDL)↑High-density lipoprotein (HDL)

30 studies1,500 participants

Supporting Studies (2)

PMID: 21427580 - L-carnitine supplementation in hemodialysis: meta-analysis (2011)PMID: 28683313 - Carnitine for dialysis patients: systematic review (2017)

Vitamin D (Calcitriol or Analogs)A

Active form as prescribed by nephrologist

Kidneys cannot activate vitamin D; supplementation essential for calcium/phosphorus balance and bone health

50 studies5,000 participants

Supporting Studies (2)

PMID: 25637462 - Vitamin D in CKD: KDIGO guidelines (2017)PMID: 30188878 - Vitamin D therapy in ESRD: systematic review (2018)

Supporting Stack

Additional supplements for enhanced results

CordycepsB

1-3g daily

Traditional kidney tonic that may support remaining renal function and reduce fatigue in CKD patients

↓Blood Urea Nitrogen (BUN)↑Serum Albumin↑Hemoglobin↓C-Reactive Protein (CRP)

12 studies600 participants

Supporting Studies (1)

PMID: 25008695 - Cordyceps sinensis for chronic kidney disease: systematic review (2014)

Coenzyme Q10C

100-200mg daily

Supports mitochondrial function and cardiovascular health; may reduce oxidative stress in dialysis

↓Blood glucose↑Glycemic Control↓HbA1c↑High-density lipoprotein (HDL)↑Insulin

10 studies400 participants

Supporting Studies (1)

PMID: 28003959 - CoQ10 in chronic kidney disease: review (2016)

Omega-3 Fatty AcidsC

2-4g EPA/DHA daily

Reduces inflammation, supports cardiovascular health, and may help maintain dialysis access patency

15 studies1,000 participants

Supporting Studies (1)

PMID: 29587088 - Omega-3 in CKD and dialysis: systematic review (2018)

ProbioticsC

10-30 billion CFU daily

May reduce uremic toxins by modulating gut bacteria and improving gut barrier function

12 studies600 participants

Supporting Studies (1)

PMID: 29228652 - Probiotics for uremic toxins in CKD: meta-analysis (2018)

B Vitamins (Water-Soluble)A

B-complex or renal vitamin as prescribed

Dialysis removes water-soluble vitamins; replacement essential to prevent deficiency

20 studies1,500 participants

Supporting Studies (1)

PMID: 24419713 - Vitamin supplementation in dialysis: guidelines (2014)

How This Protocol Works

Simple Explanation

End-stage renal disease (ESRD) means the kidneys have lost almost all function (less than 15% remaining) and dialysis or transplant is needed to survive. Because the kidneys filter blood, regulate minerals, and activate vitamin D, ESRD causes many complications: fluid and toxin buildup, mineral imbalances, anemia, bone disease, and cardiovascular problems. Supplements in ESRD require careful selection because the kidneys can't excrete excess amounts of certain nutrients.

CRITICAL: ALL supplements must be approved by your nephrologist. Many common supplements can be dangerous with kidney failure. Never take potassium, phosphorus, magnesium, or vitamins A or E supplements without explicit medical approval.

•L-Carnitine is naturally made by the body and essential for energy production in cells. Dialysis removes carnitine from the blood, leading to deficiency in most dialysis patients. Symptoms include severe fatigue, muscle weakness, and muscle cramps. Multiple studies show carnitine supplementation improves energy, reduces fatigue, and may benefit heart function and anemia response. It's often given IV after dialysis sessions.

•Vitamin D cannot be activated by failing kidneys, so nearly all ESRD patients are deficient. This leads to secondary hyperparathyroidism, bone disease, and increased cardiovascular risk. Active vitamin D (calcitriol) or vitamin D analogs (paricalcitol, doxercalciferol) are standard of care—these bypass the kidney's activation step.

•Cordyceps is a medicinal mushroom traditionally used as a 'kidney tonic' in Chinese medicine. Research shows it may help protect remaining kidney function, reduce fatigue, and improve quality of life in CKD patients. It appears to have protective effects on kidney cells.

•Coenzyme Q10 supports mitochondrial energy production and acts as an antioxidant. ESRD patients have high oxidative stress, and CoQ10 may help protect cardiovascular health—the leading cause of death in dialysis patients.

•Omega-3 Fatty Acids have anti-inflammatory and cardioprotective effects. They may help reduce cardiovascular risk and potentially help keep dialysis access (fistula/graft) functioning longer.

•Probiotics are being studied for their ability to help remove uremic toxins through the gut. The 'gut-kidney axis' is an emerging area—healthier gut bacteria may reduce the toxic burden in kidney failure.

•B Vitamins (especially B1, B6, folate, B12) are water-soluble and removed by dialysis. Deficiency is common without supplementation. Special 'renal vitamins' are formulated for dialysis patients.

Expected timeline: Carnitine for fatigue: 2-4 weeks. Vitamin D: ongoing per labs. Cordyceps: 4-8 weeks. All supplementation in ESRD is long-term management.

Clinical Perspective

End-stage renal disease (ESRD/CKD Stage 5) involves GFR <15 mL/min and requires renal replacement therapy. Pathophysiology includes uremic toxin accumulation, secondary hyperparathyroidism (CKD-MBD), anemia (EPO deficiency), cardiovascular disease (leading cause of mortality), oxidative stress, inflammation, and protein-energy wasting. Nutritional considerations are complex due to dialytic losses and accumulation risks.

CRITICAL: Supplement selection in ESRD requires nephrology oversight. Avoid: potassium (hyperkalemia risk), phosphorus (hyperphosphatemia), magnesium (accumulation), vitamin A (toxicity), high-dose vitamin C (oxalate), herbal products containing potassium/phosphorus.

•L-Carnitine (B-grade): Hemodialysis removes carnitine; 70-80% of patients become deficient. Carnitine required for fatty acid β-oxidation in mitochondria. Deficiency manifests as fatigue, muscle weakness, cardiomyopathy. Meta-analysis: supplementation improves hemoglobin/ESA response, reduces fatigue, may improve lipids (PMID: 21427580). Systematic review confirms benefits for anemia and fatigue (PMID: 28683313). FDA-approved for dialysis-associated carnitine deficiency. 10-20 mg/kg IV post-dialysis or 1-2g PO daily.

•Vitamin D (Active Forms) (A-grade): Failed kidneys cannot 1α-hydroxylate 25(OH)D to active calcitriol. Leads to hypocalcemia, hyperphosphatemia, secondary hyperparathyroidism, renal osteodystrophy. KDIGO guidelines recommend active vitamin D or analogs when PTH elevated (PMID: 25637462). Systematic review supports mortality and cardiovascular benefits (PMID: 30188878). Calcitriol, paricalcitol, or doxercalciferol per nephrologist; dose to PTH targets.

•Cordyceps (Cordyceps sinensis) (B-grade): Contains cordycepin and adenosine. Traditional use for kidney support. Mechanisms: reduces oxidative stress, anti-inflammatory, may protect tubular cells. Systematic review of clinical trials in CKD: may slow GFR decline, reduce proteinuria, improve quality of life (PMID: 25008695). Limited data specifically in ESRD. 1-3g/day. Generally well-tolerated.

•Coenzyme Q10 (C-grade): Mitochondrial electron carrier and antioxidant. ESRD patients have high oxidative stress and inflammation contributing to cardiovascular disease. Review: potential to reduce oxidative markers, support cardiac function (PMID: 28003959). Limited ESRD-specific trials. 100-200mg/day. Safe in kidney disease.

•Omega-3 Fatty Acids (C-grade): Anti-inflammatory, reduces triglycerides, may benefit dialysis access patency (conflicting data). Systematic review: potential cardiovascular benefits, may reduce inflammation in dialysis (PMID: 29587088). 2-4g/day EPA/DHA. Watch for fish-burp in dialysis patients with gastroparesis.

•Probiotics (C-grade): Gut-derived uremic toxins (indoxyl sulfate, p-cresol sulfate) contribute to inflammation and cardiovascular risk. Probiotics may reduce generation/absorption of these toxins. Meta-analysis: reduces blood urea nitrogen and inflammatory markers (PMID: 29228652). Emerging research area. 10-30 billion CFU/day; specific strains for uremic toxin reduction under study.

•B Vitamins (A-grade): Dialysis removes water-soluble vitamins. Deficiency of B1 (neurological), B6 (neuropathy), folate/B12 (anemia, hyperhomocysteinemia) common. Guidelines support routine supplementation (PMID: 24419713). Renal vitamins (Nephro-Vite, Dialyvite) formulated without vitamin A and appropriate B doses.

Biomarker targets: Adequacy (Kt/V >1.2), PTH (2-9× ULN), phosphorus (3.5-5.5 mg/dL), calcium (8.4-9.5 mg/dL), hemoglobin (10-11.5 g/dL), ferritin/TSAT, albumin, carnitine levels (if symptomatic), 25(OH)D (>30 ng/mL), inflammatory markers (CRP).

Protocol notes: Dialysis modality (HD vs PD) affects losses. Dietary protein requirements differ from pre-dialysis CKD. Avoid herbal products with unknown content. Erythropoiesis-stimulating agents (ESAs) and IV iron for anemia. Phosphate binders for hyperphosphatemia. Calcimimetics for hyperparathyroidism. Transplant evaluation if eligible. Address cardiovascular risk factors. Vaccination (Hep B, influenza, pneumococcal). Bone density monitoring. Fluid restriction per dialysis. Depression screening—common in ESRD. Palliative care discussion for patients not pursuing aggressive treatment.

View All Protocols